Pharmacogn Res 8(1):S5 Syed SN, Rizvi W, Kumar A, Khan AA, Moin S, Ahsan A (2014) In vitro antioxidant and in vivo hepatoprotective activity of leave extract of Raphanus sativus in rats using CCl 4 model
consumer guidance echoes this point (see GoodRxs explainer on clearance )
For example, it was found that carnitine as a supplement may be used to treat diabetes mellitus (29, 30), liver cirrhosis (31), dyslipidemia (32), hypertension (33), heart failure (34), coronary artery disease (35), non-alcoholic fatty liver disease (36), Alzheimers disease (37), migraine (38), and muscle injury (39)
This is for a very good reason
Revised Roberts cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157